Platelet Aggregation Devices Market Trends And Growth Analysis By Product (Systems, Reagents, Consumables And Accessories), Application (Clinical, Research Applications), End User (Hospitals And Clinics, Diagnostic Laboratories, Others)- Forecast Till 2030

Platelet Aggregation Devices Market Scenario

The platelet aggregation devices market is expected to register a healthy CAGR over the forecast period. The market held a market value of USD 2284.51 million in 2030 and is projected to grow at a CAGR of 21.50% during the forecast period. Platelet aggregation is the process wherein platelets are clumped together in the blood leading to the formation of a clot or thrombus. Factors facilitating the growth of the platelet aggregation devices market are worldwide growing older population coupled with rising prevalence of target diseases, surging number of industry-academia collaborations and clinical studies, and growth in technological developments pertaining to platelet aggregometers. However, the presence of unfavorable healthcare reforms in the US and procedural limitations are anticipated to limit the market growth over the forecast period. The World Health Organization (WHO) reported that the worldwide population aged 60 years and above was 962.0 million in 2017, which is projected to increase to over 2.0 billion by 2050 and further would reach to 3.1 billion by 2100.

Segmentation

The global platelet aggregation devices market has been segmented into product, application, and end user.

By product, the market has been segmented into systems, reagents, and consumables and accessories. In 2017, the systems segment dominated the market due to continuous technological advancements in sensors and detectors, increasing automation of platelet aggregation testing procedures, and growing adoption and market preference for automated instruments among diagnostic laboratories

On the basis of application, the market has been divided into clinical applications and research applications. The clinical applications segment is further divided into cardiovascular applications, orthopedic applications, and others.

 Based on end user, the market has been categorized into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others.

The global platelet aggregation devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The platelet aggregation devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European platelet aggregation devices market has been segmented into Western Europe and Eastern Europe. The Western Europe platelet aggregation devices market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The platelet aggregation devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The platelet aggregation devices market in the Middle East & Africa has been segmented into the Middle East and Africa.

 Regional Market Summary

 Global Platelet Aggregation Devices Market Share (%), by Region, 2017

Source: White Papers, Company Presentations, Annual Reports

Geographically, in 2017, the Americas led the global platelet aggregation devices market due to the presence of device manufacturers, surging number of surgical procedures, growing awareness among healthcare professionals (HCPs) about the benefits offered by platelet aggregation testing in disease diagnosis, and significant investments in R&D activities which utilize platelets. For instance, according to the National Center for Health Statistics, in 2009, about 48.0 million surgical inpatient procedures were performed in the US, which grew to 1.54 million in the year end 2017.

The availability of affordable platelet function tests and expanding distribution channels, surging number of cardiovascular surgeries, new technological developments in platelet aggregators, and increase in number of clinical studies in the UK, Germany, and France is expected to support the second largest position of Europe in the global market. For instance, as per the data published by the European Medicines Agency (EMA) and the British Medical Journal, approximately 4,000 clinical trials of medicines are authorized annually in the European Union (EU).

The market in Asia-Pacific would witness the fastest growth during the forecast period attributed to growing geriatric population coupled with rising prevalence of chronic diseases, increasing adoption of new technological devices, and rising incidences of mosquito-borne diseases, namely, malaria and dengue. According to the World Health Organization, severe dengue is a leading cause of serious illness and death among children in some Asian and Latin American countries. More than 40.0% of the world’s population in more than 100 countries are at risk of dengue infection. The most significant dengue epidemics in recent years have occurred in Southeast Asia, the Americas and the Western Pacific. An estimated 390.0 million dengue infections occur across the globe every year.

The platelet aggregation devices market in the Middle East & Africa would register the modest market growth rate from 2018 to 2023 owing to adoption of novel technologies, rising prevalence of hemophilia disease, improving healthcare infrastructure, and expansion of business by various market players in Gulf Cooperation Council (GCC) countries, Israel, and South Africa.

Global Platelet Aggregation Devices Market, by Product

• Systems


• Reagents


• Consumables and Accessories

Global Platelet Aggregation Devices Market, by Application

• Clinical Applications
  
  
  
  • Cardiovascular Applications
  
  
  • Orthopedic Applications
  
  
  • Others
  
  
  
  


• Research Applications

Global Platelet Aggregation Devices Market, by End User

• Hospitals and Clinics


• Diagnostic Laboratories


• Research and Academic Institutes


• Others

Global Platelet Aggregation Devices Market, by Region

• Americas
  
  
  
  • North America
    
    
    
    • US
    
    
    • Canada
    
    
    
    
  
  
  • South America
  
  
  
  


• Europe
  
  
  
  • Western Europe
    
    
    
    • Germany
    
    
    • France
    
    
    • Italy
    
    
    • Spain
    
    
    • UK
    
    
    • Rest of Western Europe
    
    
    
    
  
  
  • Eastern Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • Japan
  
  
  • China
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• The Middle East & Africa
  
  
  
  • Middle East
  
  
  • Africa
  
  
  
  

Global Platelet Aggregation Devices Market, by Key Players

• Siemens Healthineers


• Hoffmann-La Roche Ltd


• Sentinel CH. SpA


• Sysmex Corporation


• Werfen


• Helena Laboratories


• Bio/Data Corporation


• Haemonetics Corporation


• AggreDyne, Inc.


• Haemochrom Diagnostica GmbH


• Pathway Diagnostics Limited

Intended Audience

• Platelet aggregation devices manufacturers/suppliers


• Traders, distributors, wholesalers, retailers, importers and exporters


• Venture capitalists


• Contract research organizations (CROs)


• Association and government bodies


• Market research and consulting service providers


• Hospitals and clinics


• Diagnostic laboratories


• Research and academic institutes


• Corporate entities

Report Scope:

Report Attribute/Metric	Details
Market Size	2030: USD 2284.51 Million
CAGR	2020-2030: 21.50%
Base Year	2020
Forecast Period	2030
Historical Data	2018
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Product, Application and End User
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Siemens Healthineers, Hoffmann-La Roche Ltd, Sentinel CH. SpA, Sysmex Corporation, Werfen, Helena Laboratories, Bio/Data Corporation, Haemonetics Corporation, AggreDyne, Haemochrom Diagnostica GmbH, Pathway Diagnostics Limited,
Key Market Opportunities	Healthcare infrastructure, and expansion of business
Key Market Drivers	The rising prevalence of hematological diseases is the major driver for the market.

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :